Repligen (RGEN) Gains from Sales and Divestitures (2017 - 2025)
Repligen (RGEN) has disclosed Gains from Sales and Divestitures for 7 consecutive years, with $156115.0 as the latest value for Q4 2025.
- Quarterly Gains from Sales and Divestitures rose 5.18% to $156115.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $156115.0 through Dec 2025, up 5.18% year-over-year, with the annual reading at $156115.0 for FY2025, 5.18% up from the prior year.
- Gains from Sales and Divestitures for Q4 2025 was $156115.0 at Repligen, up from $139681.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $212329.0 in Q4 2021, with the low at $98246.0 in Q1 2024.
- Average Gains from Sales and Divestitures over 5 years is $154632.4, with a median of $152272.0 recorded in 2024.
- The sharpest move saw Gains from Sales and Divestitures decreased 24.14% in 2024, then grew 5.18% in 2025.
- Over 5 years, Gains from Sales and Divestitures stood at $212329.0 in 2021, then fell by 1.79% to $208531.0 in 2022, then dropped by 6.17% to $195672.0 in 2023, then fell by 24.14% to $148429.0 in 2024, then rose by 5.18% to $156115.0 in 2025.
- According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $156115.0, $139681.0, and $122517.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.